Literature DB >> 28688994

Comparison of 30-day emergency department bouncebacks after pediatric versus adult urologic surgery.

Courtney L Shepard1, Julian Wan2.   

Abstract

INTRODUCTION: More pediatric patients seem to present to the emergency department (ED) for non-urgent matters after urologic procedures than adult patients. Under new and expanding healthcare reform, pediatric urologists may be penalized for these visits. We compare our 30-day postoperative bounceback rates to the ED and the acuity of the concerns in these populations.
MATERIALS AND METHODS: All urology consults at our institution are maintained on a prospectively tracked database. We identified all patients who presented to our adult or pediatric ED between July 2013 and June 2015 within 30 days of a urologic procedure. We investigated the patient demographics including age, race, insurance, distance from the home zip code to the ED, procedures performed, chief complaint in the ED, diagnosis, and treatment required.
RESULTS: In our pediatric group, there were 67 visits for 56 patients (19 female, 37 male, mean age 6.8 years), which represents an overall bounceback incidence of 2.7%. Of those, 19% required admission (0.60% overall readmission rate), 10% underwent a procedure (0.32% reoperative rate, 18% required catheter manipulation/placement, 13% were given a prescription (most commonly for constipation), 6% required local wound care, and 33% were reassured only). Most pediatric patients had private insurance (62.5%) and those with private insurance or who were uninsured tended to require only reassurance compared to those with Medicare/Medicaid (p = 0.053). In the adult population, there were 369 visits in 310 patients (111 female, 199 male, mean age 55.4 years) for an incidence of 4.4%. Of those, 42% were admitted (2.2% overall readmission rate), 14% underwent a procedure (0.74% reoperative rate), 11% required catheter manipulation/placement, 14% were given medication (most commonly antibiotics and narcotics), 4% were given local wound care, and 12% were reassured. Most adult patients had Medicare/Medicaid (48.7%), but insurance type was not related to treatment required (p = 0.382). On multivariable analysis, pediatric patients, closer proximity to the hospital, and earlier postoperative day at presentation to the ED were predictive of requiring only reassurance.
CONCLUSIONS: Compared to adults, pediatric patients are less likely to return to the ED postoperatively (p < 0.001), but they are significantly more likely to require only reassurance (p < 0.001) while adults are significantly more likely to require hospital admission (p < 0.001). In both groups, nearly one-third of patients required only catheter care or medication. This difference could have significant implications for new healthcare policy.
Copyright © 2017 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Emergency department; Healthcare utilization; Readmission; Reoperation; Urologic surgery

Mesh:

Year:  2017        PMID: 28688994      PMCID: PMC5623629          DOI: 10.1016/j.jpurol.2017.04.024

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  15 in total

1.  Hospital readmissions--not just a measure of quality.

Authors:  Shreya Kangovi; David Grande
Journal:  JAMA       Date:  2011-10-26       Impact factor: 56.272

2.  Prospective tracking of pediatric urology consults: knowing is half the battle.

Authors:  Emilie K Johnson; Christopher P Filson; Gary J Faerber; John M Park; David A Bloom; Julian Wan
Journal:  J Urol       Date:  2012-03-16       Impact factor: 7.450

3.  Context and significance of emergency department visits and readmissions after pediatric appendectomy.

Authors:  Timothy B Lautz; Marleta Reynolds
Journal:  J Pediatr Surg       Date:  2011-10       Impact factor: 2.545

4.  Pediatric surgery readmissions: a root cause analysis.

Authors:  S Burjonrappa; A Theodorus; A Shah; I T Cohen
Journal:  Pediatr Surg Int       Date:  2015-04-16       Impact factor: 1.827

5.  Hospital admissions through the emergency department: does insurance status matter?

Authors:  C M Sox; H R Burstin; R A Edwards; A C O'Neil; T A Brennan
Journal:  Am J Med       Date:  1998-12       Impact factor: 4.965

6.  Return to system within 30 days of discharge following pediatric non-shunt surgery.

Authors:  Samir Sarda; Markus Bookland; Jason Chu; Mohammadali M Shoja; Matthew P Miller; Stephen B Reisner; Philip H Yun; Joshua J Chern
Journal:  J Neurosurg Pediatr       Date:  2014-10-17       Impact factor: 2.375

7.  Thirty-days readmissions in pediatric surgery: The first U.K. experience.

Authors:  C K Sinha; E Decker; D Rex; Z Mukhtar; F Murphy; E Nicholls; B Okoye; S Giuliani
Journal:  J Pediatr Surg       Date:  2016-07-05       Impact factor: 2.545

8.  Causes and risk factors for 30-day unplanned readmissions after pediatric spinal deformity surgery.

Authors:  Christopher T Martin; Andrew J Pugely; Yubo Gao; Stuart L Weinstein
Journal:  Spine (Phila Pa 1976)       Date:  2015-02-15       Impact factor: 3.468

9.  Return to system within 30 days of discharge following pediatric shunt surgery.

Authors:  Joshua J Chern; Markus Bookland; Javier Tejedor-Sojo; Jonathan Riley; Mohammadali M Shoja; R Shane Tubbs; Andrew Reisner
Journal:  J Neurosurg Pediatr       Date:  2014-03-14       Impact factor: 2.375

10.  Emergency Department Visits and Readmissions among Children after Gastrostomy Tube Placement.

Authors:  Adam B Goldin; Kurt F Heiss; Matt Hall; David H Rothstein; Peter C Minneci; Martin L Blakely; Marybeth Browne; Mehul V Raval; Samir S Shah; Shawn J Rangel; Charles L Snyder; Charles D Vinocur; Loren Berman; Jennifer N Cooper; Marjorie J Arca
Journal:  J Pediatr       Date:  2016-04-11       Impact factor: 4.406

View more
  1 in total

1.  Postoperative course following complex major pediatric urologic surgery: A single surgeon experience.

Authors:  Aaron Wallace; Maria Veronica Rodriguez; Mohan S Gundeti
Journal:  J Pediatr Surg       Date:  2018-12-28       Impact factor: 2.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.